ZNF740 and acute myeloid leukemia: Since elevated ZNF740 expression correlates with increased sensitivity to venetoclax in primary AML samples (Fig. 1E), we examined if enhancing ZNF740 expression would further sensitize AML cells to venetoclax treatment.